Literature DB >> 7192586

Is the diurnal increase of fibrinolytic activity influenced by alpha- or beta-adrenergic blockade?

J Harenberg, E Weber, U Spohr, H Mörl.   

Abstract

The diurnal increase of fibrinolytic activity in the forenoon was investigated after alpha- and beta-adrenergic blockade in 15 volunteers. Four milligrams propranolol was injected i. v. alone or in combination with 20 mg phentolamine. Neither the beta-blocking agent, propranolol, nor the combination with the alpha-blocker, phentolamine, had any significant effect on the diurnal increase of fibrinolytic activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192586     DOI: 10.1007/bf01007771

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  6 in total

1.  ENHANCING THE FIBRINOLYTIC ACTIVITY OF THE BLOOD BY VASOACTIVE DRUGS.

Authors:  R HOLEMANS
Journal:  Med Exp Int J Exp Med       Date:  1963

2.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

3.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

4.  [The intraindividual variation of fibrinolytic activity in volunteers (author's transl)].

Authors:  J Harenberg; E Walter; E Weber
Journal:  Klin Wochenschr       Date:  1978-05-01

5.  Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise.

Authors:  D R Rosing; P Brakman; D R Redwood; R E Goldstein; G D Beiser; T Astrup; S E Epstein
Journal:  Circ Res       Date:  1970-08       Impact factor: 17.367

6.  Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man.

Authors:  C M Hawkey; B J Britton; W G Wood; M Peele; M H Irving
Journal:  Br J Haematol       Date:  1975-03       Impact factor: 6.998

  6 in total
  1 in total

1.  Hypercoagulability after immunotherapy with Corynebacterium parvum in man.

Authors:  J Harenberg; A Baumgärtner; D Fritze; R Zimmermann
Journal:  Blut       Date:  1982-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.